Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,451,914
+$29,075 QoQ
Shares Held
6,771
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,162
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. AMGN ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
This page
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,037 | $775,754 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,451,914 | 6,771 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,422,839 | 6,886 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,339,284 | 7,147 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,106,905 | 7,466 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,114,736 | 7,574 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,364,352 | 7,589 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,050,976 | 7,869 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,533,215 | 7,862 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,489,601 | 7,968 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,367,532 | 8,327 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,436,361 | 8,459 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,283,116 | 8,495 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,891,610 | 8,520 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,057,776 | 8,512 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $2,246,359 | 8,553 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,175,786 | 9,653 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,384,583 | 9,801 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,375,639 | 9,824 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,224,728 | 9,889 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,112,039 | 9,932 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,426,287 | 9,954 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,489,095 | 10,004 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,300,119 | 10,004 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,542,616 | 10,004 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $2,364,968 | 10,027 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,046,153 | 10,093 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||